DelSiTech to Present at ARVO 2019 Vancouver, April 28 – May 2 Marcus Reay2019-04-01T17:03:56+03:00March 30th, 2019| Read More
Meet DelSiTech at BIO-Europe Spring 2019 Vienna, March 25-27 Marcus Reay2019-03-08T12:28:11+03:00March 7th, 2019| Read More
DelSiTech Featured in Pharma Technology Article: “2019 is set to be an exciting year for DelSiTech and its Silica Matrix”. Marcus Reay2019-02-25T16:44:40+03:00February 25th, 2019| Read More
DelSiTech and Innovare Sign Licensing Agreement for the Development of a Long Acting HIV Therapy Lasse Leino2019-04-18T14:22:03+03:00December 18th, 2018| Read More
DelSiTech Ltd Receives Funding for the Stabilization of Viral Vaccines – Awarded a grant for vaccine development by the Bill & Melinda Gates Foundation Lasse Leino2018-10-24T11:34:06+03:00October 24th, 2018| Read More
Drug Delivery Company DelSiTech Ltd Announces Appointment of Professor Reijo Salonen to Its Board of Directors admin@delsitech.com2018-03-28T07:56:31+03:00January 4th, 2018| Read More
DelSiTech Ltd and C-Tri Co. Ltd Sign a Collaboration Agreement to Develop Innovative Drug Delivery Technology Product for Oncology admin@delsitech.com2018-03-28T07:56:12+03:00December 18th, 2017| Read More
DelSiTech Featured in a Recent Ocular Drug Delivery Business Report admin@delsitech.com2018-02-28T19:41:12+03:00August 22nd, 2017| Read More
DelSiTech and Bayer Partner to Develop Innovative Drug Delivery Technology for Ophthalmology admin@delsitech.com2018-03-28T07:56:42+03:00September 29th, 2016| Read More
